קם-רהו די

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

ANTI-D IMMUNOGLOBULINS

Disponibil de la:

KAMADA LTD, ISRAEL

Codul ATC:

J06BB01

Forma farmaceutică:

תמיסה להזרקה

Compoziție:

ANTI-D IMMUNOGLOBULINS 150 MCG / 1 ML

Calea de administrare:

תוך-ורידי

Tip de prescriptie medicala:

מרשם נדרש

Produs de:

KAMADA LTD, ISRAEL

Grupul Terapeutică:

ANTI-D (RH) IMMUNOGLOBULIN

Zonă Terapeutică:

ANTI-D (RH) IMMUNOGLOBULIN

Indicații terapeutice:

Suppression of Rh immunization in non-sensitized Rho(D) negative women delivering an Rh positive baby, or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions, threatened abortion associated with maternal bleeding amniocentesis, chorionic villus sampling ruptured tubal pregnancy, and significant abdominal trauma. KAM-Rho should be given within 72 hours of event. Immune thrombocytopenic purpura (ITP): Rho (d)-positive adults with chronic ITP, children with chronic or acute ITP, and patients with Thrombocytopenia secondary to HIV infection in clinical situations requiring an increase in platelet count to prevent excessive hemorrhage.

Data de autorizare:

2013-03-31